Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


1 Ann Surg Oncol
1 Asian Pac J Cancer Prev
1 Biochem Biophys Res Commun
1 Can Urol Assoc J
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Genomics Proteomics
1 Curr Oncol Rep
1 Curr Opin Urol
1 Curr Probl Diagn Radiol
2 Eur Urol
1 Int J Med Robot
1 Int J Surg Pathol
1 J Cell Biochem
1 Medicine (Baltimore)
1 Mol Med
1 Muscle Nerve
5 Oncol Lett
1 Oncol Rep
2 PLoS One
1 Pract Radiat Oncol
1 Sci Rep
3 Urol Oncol
1 Urology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Surg Oncol

  1. WU CT, Lin WY, Chen WC, Chen MF, et al
    Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
    Ann Surg Oncol. 2018 Aug 20. pii: 10.1245/s10434-018-6706.
    PubMed     Text format     Abstract available

    Asian Pac J Cancer Prev

  2. ABOUSHOUSHA T, Hammam O, Helal N, El Dahshan S, et al
    Impact of Cyclin D1 and Heterogeneous Nuclear Ribonucleoprotein-K (HnRNP-K) on Urinary Bladder Carcinogenesis
    Asian Pac J Cancer Prev. 2018;19:513-519.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  3. TANG Y, Cong X, Wang S, Fang S, et al
    GnT-V promotes chemosensitivity to gemcitabine in bladder cancer cells through beta1,6 GlcNAc branch modification of human equilibrative nucleoside transporter 1.
    Biochem Biophys Res Commun. 2018 Aug 21. pii: S0006-291X(18)31790.
    PubMed     Text format     Abstract available

    Can Urol Assoc J

  4. LIU B, Domes T, Jana K
    Evaluation of an enhanced recovery protocol on patients having radical cystectomy for bladder cancer.
    Can Urol Assoc J. 2018 Jul 31. pii: cuaj.5273. doi: 10.5489/cuaj.5273.
    PubMed     Text format     Abstract available

    Cancer Epidemiol Biomarkers Prev

  5. WADA K, Tsuji M, Tamura T, Konishi K, et al
    Soy isoflavone intake and bladder cancer risk in Japan: From the Takayama study.
    Cancer Epidemiol Biomarkers Prev. 2018 Aug 21. pii: 1055-9965.EPI-18-0283.
    PubMed     Text format     Abstract available

    Cancer Genomics Proteomics

  6. WHONGSIRI P, Pimratana C, Wijitsettakul U, Jindatip D, et al
    LINE-1 ORF1 Protein Is Up-regulated by Reactive Oxygen Species and Associated with Bladder Urothelial Carcinoma Progression.
    Cancer Genomics Proteomics. 2018;15:143-151.
    PubMed     Text format     Abstract available

    Curr Oncol Rep

  7. MCCONKEY DJ, Choi W
    Molecular Subtypes of Bladder Cancer.
    Curr Oncol Rep. 2018;20:77.
    PubMed     Text format     Abstract available

    Curr Opin Urol

  8. DYRSKJOT L, Ingersoll MA
    Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology.
    Curr Opin Urol. 2018 Aug 21. doi: 10.1097/MOU.0000000000000543.
    PubMed     Text format     Abstract available

    Curr Probl Diagn Radiol

  9. HARRI PA, Alexander L, Camacho JC, Moreno CC, et al
    Magnetic Resonance Imaging Evaluation of Urothelial Cell Carcinoma: Histopathological Correlation, Staging, and Treatment Planning.
    Curr Probl Diagn Radiol. 2018;47:28-41.
    PubMed     Text format    

    Eur Urol

  10. GIANNARINI G, Crestani A, Ficarra V
    Re: Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial.
    Eur Urol. 2018 Aug 20. pii: S0302-2838(18)30564.
    PubMed     Text format    

  11. LEE B, Kim JH
    Re: Alan D. Uren, Nikki Cotterill, Christopher Harding, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol 2017;72:402-7.
    Eur Urol. 2018;73:e13-e14.
    PubMed     Text format    


  12. LI J, Ying Y, Xie H, Jin K, et al
    Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.
    FASEB J. 2018 Aug 23:fj201800667R. doi: 10.1096/fj.201800667.
    PubMed     Text format     Abstract available

    Int J Med Robot

  13. KOIE T, Ohyama C, Yoneyama T, Nagasaka H, et al
    Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.
    Int J Med Robot. 2018 Aug 23:e1955. doi: 10.1002/rcs.1955.
    PubMed     Text format     Abstract available

    Int J Surg Pathol

  14. FELDMAN A, Borak S, Rais-Bahrami S, Gordetsky J, et al
    Secondary Malignancies of the Bladder: Avoiding the Diagnostic Pitfall.
    Int J Surg Pathol. 2018;26:120-125.
    PubMed     Text format     Abstract available

    J Cell Biochem

  15. FENG F, Chen A, Huang J, Xia Q, et al
    Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/beta-catenin pathway axis.
    J Cell Biochem. 2018 Aug 21. doi: 10.1002/jcb.27257.
    PubMed     Text format     Abstract available

    Medicine (Baltimore)

  16. BI Y, Chen S, Jiang J, Yao J, et al
    CDCA8 expression and its clinical relevance in patients with bladder cancer.
    Medicine (Baltimore). 2018;97:e11899.
    PubMed     Text format     Abstract available

    Mol Med

  17. WU Z, Huang W, Wang X, Wang T, et al
    Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11.
    Mol Med. 2018;24:40.
    PubMed     Text format     Abstract available

    Muscle Nerve

  18. DAVALOS L, Kushlaf H
    New onset of seropositive generalized myasthenia gravis following intravesical Bacille Calmette-Guerin treatment for bladder cancer: A case study.
    Muscle Nerve. 2018 Aug 25. doi: 10.1002/mus.26328.
    PubMed     Text format    

    Oncol Lett

  19. XIU W, Ma J, Lei T, Zhang M, et al
    AG490 reverses phenotypic alteration of dendritic cells by bladder cancer cells.
    Oncol Lett. 2018;16:2851-2856.
    PubMed     Text format     Abstract available

  20. SYRING I, Weiten R, Muller T, Schmidt D, et al
    The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy.
    Oncol Lett. 2018;16:3013-3021.
    PubMed     Text format     Abstract available

  21. LI T, Xu K, Liu Y
    Anticancer effect of salidroside reduces viability through autophagy/PI3K/Akt and MMP-9 signaling pathways in human bladder cancer cells.
    Oncol Lett. 2018;16:3162-3168.
    PubMed     Text format     Abstract available

  22. LU P, Cui J, Chen K, Lu Q, et al
    Diagnostic accuracy of the UBC((R)) Rapid Test for bladder cancer: A meta-analysis.
    Oncol Lett. 2018;16:3770-3778.
    PubMed     Text format     Abstract available

  23. GUO L, Yin M, Wang Y
    CREB1, a direct target of miR-122, promotes cell proliferation and invasion in bladder cancer.
    Oncol Lett. 2018;16:3842-3848.
    PubMed     Text format     Abstract available

    Oncol Rep

  24. XU ZL, Zhang Y, Wang L, Li F, et al
    B7H3 promotes malignant progression of muscleinvasive bladder cancer.
    Oncol Rep. 2018 Aug 17. doi: 10.3892/or.2018.6655.
    PubMed     Text format     Abstract available

    PLoS One

  25. GARCZYK S, Schneider U, Lurje I, Becker K, et al
    ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
    PLoS One. 2018;13:e0202965.
    PubMed     Text format     Abstract available

  26. SUTTON AJ, Lamont JV, Evans RM, Williamson K, et al
    An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer.
    PLoS One. 2018;13:e0202796.
    PubMed     Text format     Abstract available

    Pract Radiat Oncol

  27. COOPER CT, Greene BD, Fegan JE, Rovira D, et al
    External beam radiation therapy for amyloidosis of the urinary bladder.
    Pract Radiat Oncol. 2018;8:25-27.
    PubMed     Text format    

    Sci Rep

  28. WANG Y, Chang Q, Li Y
    Racial differences in Urinary Bladder Cancer in the United States.
    Sci Rep. 2018;8:12521.
    PubMed     Text format     Abstract available

    Urol Oncol

  29. MIKI M, Ishii K, Sasaki T, Kato M, et al
    Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme.
    Urol Oncol. 2018 Aug 20. pii: S1078-1439(18)30263.
    PubMed     Text format     Abstract available

  30. GILD P, Wankowicz SA, Sood A, von Landenberg N, et al
    Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis.
    Urol Oncol. 2018 Aug 20. pii: S1078-1439(18)30267.
    PubMed     Text format     Abstract available

  31. GOPALAKRISHNA A, Chang A, Longo TA, Fantony JJ, et al
    Dietary patterns and health-related quality of life in bladder cancer survivors.
    Urol Oncol. 2018 Aug 17. pii: S1078-1439(18)30200.
    PubMed     Text format     Abstract available


  32. HAN DS, Zhou W, Seigne JD, Lynch KE, et al
    Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries.
    Urology. 2018 Aug 20. pii: S0090-4295(18)30835.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.